Viewing StudyNCT00381342



Ignite Creation Date: 2024-05-05 @ 5:05 PM
Last Modification Date: 2024-10-26 @ 9:27 AM
Study NCT ID: NCT00381342
Status: COMPLETED
Last Update Posted: 2015-02-23
First Post: 2006-09-25

Brief Title: Safety and Efficacy of Exenatide as Monotherapy
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Type 2 Diabetes Mellitus
Keywords:
Name View
monotherapy View
diabetes View
exenatide View
Amylin View
Lilly View